Comparison of biochemical and immunological profile of pediatric patients with acute myeloid leukemia in relation to healthy individuals

Sanches, Fabiane L.F.Z.; Nitsch, Taís M.; Vilela, Maria Marluce S.; Sgarbieri, Valdemiro C..
J. pediatr. (Rio J.) ; 91(5): 478-484, Sept.-Oct. 2015. tab, graf
Artigo em Inglês | LILACS | ID: lil-766167

Documentos relacionados

  1. Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.
  2. Developing DNA methylation-based prognostic biomarkers of acute myeloid leukemia.
  3. Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research.
  4. DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia.
  5. SpinTip: A Simple, Robust, and Versatile Preanalytical Method for Microscale Suspension Cell Proteomics.
  6. GPAM mediated lysophosphatidic acid synthesis regulates mitochondrial dynamics in acute myeloid leukemia.
  7. Molecular Insight into Iron Homeostasis of Acute Myeloid Leukemia Blasts.
  8. Isocitrate Dehydrogenase Mutation and (R)-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development.
  9. The palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML.
  10. Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1.